In-licensing
Up-to-date access to technology licensing opportunities worldwide.
- In-licensing
- Browse
Licensing opportunities
We are focused on licensing or acquiring new, late-stage technologies or existing prescription or OTC dermatology products More
Seeking opportunities for consumer healthcare products and molecules with Rx-to-OTC switch potential
OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential. More
APR is interested to in-license new early stage, innovative and patent protected products/technologies (preferably off patent or close to expiry) for oral, topical or transdermal administration More
Our analgesic specialists are seeking a new, innovative and novel patch product for the treatment of pain to add to their portfolio. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2011 - 124 pages - $1,740
Jun 2009 - 118 pages - $1,040
Nov 2009 - 830 pages - $1,040
Nov 2010 - 428 pages - $2,695
Jun 2009 - 110 pages - $1,040
Nov 2010 - 185 pages - $1,495
Jun 2009 - 472 pages - $3,140
Jun 2008 - 175 pages - $3,835
Oct 2010 - 97 pages - $3,835
Jul 2010 - 27 pages - $750
Your selection
Browse By
- Industry sector
- Intravesical
- Nasal
- Nasal topical
- Ophthalmic
- Oral liquid
- Oral solid
- Otic
- Parenteral
- Pulmonary
- Rectal
- Systemic
- Topical
- Vaginal
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us